Marvin M Kobric

Title: Marvin M. Kobric: Innovator in Peptide Therapeutics

Introduction

Marvin M. Kobric is a notable inventor based in St. Laurent, Canada. He has made significant contributions to the field of peptide therapeutics, particularly in the treatment of acromegaly and diabetes. His innovative work has led to the development of valuable pharmaceutical compounds.

Latest Patents

Kobric holds a patent for "Carba decapeptide derivatives of [TYR.sup.6]-somatostatin." This patent describes peptides of formula I, where X can be (CH.sub.2).sub.2, S--CH.sub.2, or CH.sub.2--S, or a therapeutically acceptable acid addition salt thereof. These peptides are recognized for their potential in treating acromegaly and managing diabetes in mammals. The patent also includes compositions and methods for the preparation of these peptides.

Career Highlights

Marvin M. Kobric has been associated with Ayerst, McKenna & Harrison, Inc., where he has contributed to the advancement of peptide-based therapies. His work has been instrumental in developing innovative solutions for complex medical conditions.

Collaborations

Kobric has collaborated with notable colleagues, including Nedumparampil A. Abraham and Francesco Bellini. These partnerships have fostered a collaborative environment that enhances research and development in the field of peptide therapeutics.

Conclusion

Marvin M. Kobric's contributions to peptide therapeutics exemplify the impact of innovation in medicine. His work continues to influence the treatment of significant health conditions, showcasing the importance of research and development in the pharmaceutical industry.